Optimal SCLC Care With Established and Innovative Therapies
Вставка
- Опубліковано 17 лип 2024
- This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/HXN865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 2, 2025.
Achieving Optimal SCLC Care With Established and Innovative Therapies: Latest Evidence, Key Ongoing Trials, and Practical Considerations for Real-World Practice
In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by independent medical educational grants provided by Amgen, AstraZeneca, Daiichi Sankyo, Inc., and Jazz Pharmaceuticals.
Disclosure information is available at the beginning of the video presentation.